无创神经监测在重症监护中的实施要点
该研究旨在识别联合多种无创神经监测方式的实施挑战,选取盲法经颅多普勒超声、视神经鞘直径测量、多通道连续脑电图(cEEG)、自动瞳孔测量、近红外光谱(NIRS)和颅骨延伸计(Brain4Care)六种方式。专家组提出无创神经监测多模态准备度(nnMR)评分,基于数据连续性与处理、生理信号表征、空间与时间分辨率、ICU软件整合等标准进行结构化评估。nnMR评分显示cEEG和NIRS可连续监测无需手动处理;盲法经颅多普勒和NIRS时间分辨率好,视神经鞘直径空间分辨率好,cEEG和颅骨延伸计兼具两者;仅cEEG具备解剖清晰度;所有方式软件整合均有限。多模态实施的关键挑战包括需要熟练人员、伪差易感性、时间与空间分辨率不匹配、长期信号稳定性有限,以及缺乏标准化导致需单独手动输入、处理和量化。
要点
- 专家组提出nnMR评分,从数据连续性与处理、生理信号表征、空间与时间分辨率、ICU软件整合四方面评估六种无创神经监测方式的多模态准备度。
- cEEG和NIRS可连续监测且无需手动处理;盲法经颅多普勒和NIRS时间分辨率好,视神经鞘直径空间分辨率好,cEEG和颅骨延伸计兼具时间与空间分辨率。
- 仅cEEG具备解剖清晰度;所有六种方式的软件整合均有限。
- 多模态实施的关键挑战包括需要熟练人员、伪差易感性、时间与空间分辨率不匹配、长期信号稳定性有限。
- 整合入统一分析平台受限于缺乏标准化,需单独手动数据输入、处理和量化;验证nnMR评分需更广泛神经重症监护界参与。
适用人群与场景
- 重症监护病房中需要个体化脑生理与功能监测的危重患者
诊断标准与关键阈值
- nnMR评分基于数据连续性与处理、生理信号表征、空间与时间分辨率、ICU软件整合等标准对每种监测方式进行结构化评估
研究设计与关键结果
- 研究为专家组提出nnMR评分以评估六种无创神经监测方式(盲法经颅多普勒超声、视神经鞘直径测量、多通道cEEG、自动瞳孔测量、NIRS、颅骨延伸计Brain4Care)的多模态整合准备度。
- nnMR评分显示cEEG和NIRS可连续监测无需手动处理;盲法经颅多普勒和NIRS时间分辨率好,视神经鞘直径空间分辨率好,cEEG和颅骨延伸计兼具时间与空间分辨率。
- 仅cEEG具备解剖清晰度;所有方式软件整合均有限。
- 多模态实施的关键挑战包括需要熟练人员、伪差易感性、时间与空间分辨率不匹配、长期信号稳定性有限。
- 整合入统一分析平台受限于缺乏标准化,需单独手动数据输入、处理和量化。
证据类型、等级与局限
- 证据类型:专家意见(专家组提出nnMR评分)
- 局限:原文未报告局限性
对床旁实践的改变
- 作者认为nnMR评分可用于评估每种无创神经监测方式当前用于多模态、连续和长期临床应用的准备度。
- 作者认为实现多模态神经监测的全部潜力需要信号验证、软件整合、分辨率对齐、伪差检测、固定技术和标准化方面的进步,以及研究者、工程师、制造商和临床医生之间的密切合作。
- 作者认为验证所提出的nnMR评分必须与更广泛的神经重症监护界合作。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Noninvasive neuromonitoring provides valuable insights into cerebral physiology and function, with the potential to support individualized care for patients who are critically ill. As precision medicine continues to advance within the intensive care unit, the integration of multiple noninvasive monitoring techniques may offer a more comprehensive, real-time understanding of dynamic cerebral pathophysiology while avoiding the risks of invasive procedures. This study aimed to identify the implementation challenges of combining multiple noninvasive neuromonitoring modalities. Six modalities were selected: blind transcranial Doppler ultrasonography, optic nerve sheath diameter measurement, multichannel continuous electroencephalography (cEEG), automated pupillometry, near-infrared spectroscopy (NIRS), and skull extensometer (Brain4Care).
METHODS: To assess the readiness of each modality for integration into a multimodal noninvasive monitoring setup, a group of experts propose the Noninvasive Neuromonitoring Multimodal Readiness (nnMR) score. This scoring system aims to provide a structured evaluation of each modality's multimodal suitability based on criteria such as data continuity and processing, physiological signal representation, spatial and temporal resolution, and software integration in the intensive care unit setting.
RESULTS: nnMR scores showed that cEEG and NIRS enable continuous monitoring without manual processing. Blind transcranial Doppler and NIRS offer a good temporal resolution; optic nerve sheath diameter provides good spatial resolution; cEEG and skull extensometer combine both. Only cEEG demonstrates anatomical clarity. Software integration remains limited across all modalities. Key challenges to multimodal implementation include the need for skilled personnel, artifact susceptibility, mismatched temporal and spatial resolutions, and limited long-term signal stability. Integration into unified analytical platforms is further constrained by a lack of standardization, requiring separate manual data input, processing, and quantification.
CONCLUSIONS: The nnMR score was developed to assess the current readiness of each modality for multimodal, continuous, and long-term clinical application. To validate the proposed nnMR score, engagement with the broader neurocritical care community is essential. Realizing the full potential of multimodal neuromonitoring will require advances in signal validation, software integration, resolution alignment, artifact detection, fixation techniques, and standardization, necessitating close collaboration among researchers, engineers, manufacturers, and clinicians.
参考来源
- Kishna YS, Robba C, van der Horst ICC, et al. Practicalities of noninvasive neuromonitoring in intensive care. Neurocrit Care. 2025. PMID: 41239165. doi:10.1007/s12028-025-02405-y
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。